Publications by authors named "Liaoxin Luo"

Claim this Profile
A
ANP32E expression in pancreatic cancer is associated with impaired gemcitabine efficacy and poor patient prognosis.
Xiaohong Liu, Yelin Zhao, Li Zhang, Junting Wang, Liaoxin Luo

Mol Cell Probes· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug screening approaches for small-molecule compounds in cancer-targeted therapy.
Yelin Zhao, Chenyu Yuan, Yuchen Shi, Xiaohong Liu, Liaoxin Luo

J Drug Target· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New insight into the role of SMAD4 mutation/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas.
Hongjuan Yao, Liaoxin Luo, Rui Li, Yelin Zhao, Li Zhang

Biochim Biophys Acta Rev Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis